Literature DB >> 1525758

Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation.

J A Thomas1, M W Scriven, M C Puntis, B Jasani, G T Williams.   

Abstract

Hepatobiliary cystadenomas with mesenchymal stroma (CMS) are rare tumors. Two cases are reported that illustrate many features of CMS, including polypoid involvement of the common hepatic duct in one case. Both tumors were associated with elevated serum levels of the tumor-associated antigen CA 19-9 but normal levels of carcinoembryonic antigen and alpha-fetoprotein. Immunohistochemical analysis confirmed the presence of CA 19-9 in the epithelial component of the tumor. The implications of these findings are discussed, both in relation to the histogenesis of CMS and its preoperative diagnosis. A minimally elevated level of CA 19-9 was found in only one of five patients with hydatid disease of the liver, an important differential diagnosis in clinical management.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525758     DOI: 10.1002/1097-0142(19921001)70:7<1841::aid-cncr2820700706>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Giant intrahepatic biliary cystadenoma in a male: a case report, immunohistopathological analysis, and review of the literature.

Authors:  Shinsuke Kazama; Takeyuki Hiramatsu; Shigeru Kuriyama; Ken Kuriki; Ryo Kobayashi; Naoki Takabayashi; Kenichi Furukawa; Masami Kosukegawa; Hitoshi Nakajima; Kousuke Hara
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

2.  Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas.

Authors:  T Terada; Y Kitamura; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

3.  Ruptured biliary cystadenoma managed by angiographic embolization and interval partial hepatectomy.

Authors:  Saif A Ghole; Sara Bakhtary; Kristan Staudenmayer; Daniel Y Sze; Reetesh K Pai; Brendan C Visser; Jeffrey A Norton; George A Poultsides
Journal:  Dig Dis Sci       Date:  2011-03-29       Impact factor: 3.199

Review 4.  Intra and extra-hepatic cystadenoma of the biliary duct. Review of literature and radiological and pathological characteristics of a very rare case.

Authors:  Diana Soochan; Valerie Keough; Ian Wanless; Michele Molinari
Journal:  BMJ Case Rep       Date:  2012-04-04

Review 5.  Mucinous biliary cystadenoma with mesenchymal stroma: expressions of CA 19-9 and carcinoembryonic antigen in serum and cystic fluid.

Authors:  J H Lee; D R Chen; S C Pang; Y S Lai
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

6.  Mucinous cystic neoplasm of the liver with biliary communication: an exception to the current classification.

Authors:  Santhosh Anand; Sandip Chandrasekar; Kalayarasan Raja; Biju Pottakkat
Journal:  BMJ Case Rep       Date:  2019-01-10

Review 7.  Rare cystic liver lesions: a diagnostic and managing challenge.

Authors:  Andreas Bakoyiannis; Spiros Delis; Charina Triantopoulou; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma.

Authors:  Kevin C Soares; Dean J Arnaoutakis; Ihab Kamel; Robert Anders; Reid B Adams; Todd W Bauer; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-09-14       Impact factor: 6.113

9.  The accuracy of pre-operative imaging in the management of hepatic cysts.

Authors:  Alexandre Doussot; Jill Gluskin; Bas Groot-Koerkamp; Peter J Allen; Ronald P De Matteo; Jinru Shia; T Peter Kingham; William R Jarnagin; Scott R Gerst; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2015-07-30       Impact factor: 3.647

10.  Cystadenoma of the liver without mesenchymal stroma in a female following hormonal therapy for acne.

Authors:  E Dixon; F R Sutherland; K Burak; G McKinnon; G May
Journal:  HPB (Oxford)       Date:  2001       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.